Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Asfandyar Sikandar
  • Katarina Cirnski
  • Giambattista Testolin
  • Carsten Volz
  • Mark Brönstrup
  • Olga V. Kalinina
  • Rolf Müller
  • Jesko Koehnke

External Research Organisations

  • Max-Planck Institute for Informatics
  • Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
  • German Center for Infection Research (DZIF)
  • Saarland University
  • Helmholtz Centre for Infection Research (HZI)
View graph of relations

Details

Original languageEnglish
Pages (from-to)16641-16649
Number of pages9
JournalJournal of the American Chemical Society
Volume140
Issue number48
Publication statusPublished - 5 Dec 2018
Externally publishedYes

Abstract

To combat the rise of antimicrobial resistance, the discovery of new antibiotics is paramount. Albicidin and cystobactamid are related natural product antibiotics with potent activity against Gram-positive and, crucially, Gram-negative pathogens. AlbA has been reported to neutralize albicidin by binding it with nanomolar affinity. To understand this potential resistance mechanism, we determined structures of AlbA and its complex with albicidin. The structures revealed AlbA to be comprised of two domains, each unexpectedly resembling the multiantibiotic neutralizing protein TipA. Binding of the long albicidin molecule was shared pseudosymmetrically between the two domains. The structure also revealed an unexpected chemical modification of albicidin, which we demonstrate to be promoted by AlbA, and to reduce albicidin potency; we propose a mechanism for this reaction. Overall, our findings suggest that AlbA arose through internal duplication in an ancient TipA-like gene, leading to a new binding scaffold adapted to the sequestration of long-chain antibiotics.

ASJC Scopus subject areas

Cite this

Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA. / Sikandar, Asfandyar; Cirnski, Katarina; Testolin, Giambattista et al.
In: Journal of the American Chemical Society, Vol. 140, No. 48, 05.12.2018, p. 16641-16649.

Research output: Contribution to journalArticleResearchpeer review

Sikandar, A, Cirnski, K, Testolin, G, Volz, C, Brönstrup, M, Kalinina, OV, Müller, R & Koehnke, J 2018, 'Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA', Journal of the American Chemical Society, vol. 140, no. 48, pp. 16641-16649. https://doi.org/10.1021/jacs.8b08895
Sikandar, A., Cirnski, K., Testolin, G., Volz, C., Brönstrup, M., Kalinina, O. V., Müller, R., & Koehnke, J. (2018). Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA. Journal of the American Chemical Society, 140(48), 16641-16649. https://doi.org/10.1021/jacs.8b08895
Sikandar A, Cirnski K, Testolin G, Volz C, Brönstrup M, Kalinina OV et al. Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA. Journal of the American Chemical Society. 2018 Dec 5;140(48):16641-16649. doi: 10.1021/jacs.8b08895
Sikandar, Asfandyar ; Cirnski, Katarina ; Testolin, Giambattista et al. / Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA. In: Journal of the American Chemical Society. 2018 ; Vol. 140, No. 48. pp. 16641-16649.
Download
@article{2c41c6ba637f4d759a371e2317e608a3,
title = "Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA",
abstract = "To combat the rise of antimicrobial resistance, the discovery of new antibiotics is paramount. Albicidin and cystobactamid are related natural product antibiotics with potent activity against Gram-positive and, crucially, Gram-negative pathogens. AlbA has been reported to neutralize albicidin by binding it with nanomolar affinity. To understand this potential resistance mechanism, we determined structures of AlbA and its complex with albicidin. The structures revealed AlbA to be comprised of two domains, each unexpectedly resembling the multiantibiotic neutralizing protein TipA. Binding of the long albicidin molecule was shared pseudosymmetrically between the two domains. The structure also revealed an unexpected chemical modification of albicidin, which we demonstrate to be promoted by AlbA, and to reduce albicidin potency; we propose a mechanism for this reaction. Overall, our findings suggest that AlbA arose through internal duplication in an ancient TipA-like gene, leading to a new binding scaffold adapted to the sequestration of long-chain antibiotics.",
author = "Asfandyar Sikandar and Katarina Cirnski and Giambattista Testolin and Carsten Volz and Mark Br{\"o}nstrup and Kalinina, {Olga V.} and Rolf M{\"u}ller and Jesko Koehnke",
note = "Funding Information: J.K. acknowledges the DFG for an Emmy-Noether Fellowship (KO 4116/3-1). We thank Daniel Sauer for the help he provided with mass spectrometry and Prof. Lawrence Shapiro for critical reading of the manuscript. We are grateful for access to ESRF beamlines ID29 and ID23-1.",
year = "2018",
month = dec,
day = "5",
doi = "10.1021/jacs.8b08895",
language = "English",
volume = "140",
pages = "16641--16649",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "48",

}

Download

TY - JOUR

T1 - Adaptation of a Bacterial Multidrug Resistance System Revealed by the Structure and Function of AlbA

AU - Sikandar, Asfandyar

AU - Cirnski, Katarina

AU - Testolin, Giambattista

AU - Volz, Carsten

AU - Brönstrup, Mark

AU - Kalinina, Olga V.

AU - Müller, Rolf

AU - Koehnke, Jesko

N1 - Funding Information: J.K. acknowledges the DFG for an Emmy-Noether Fellowship (KO 4116/3-1). We thank Daniel Sauer for the help he provided with mass spectrometry and Prof. Lawrence Shapiro for critical reading of the manuscript. We are grateful for access to ESRF beamlines ID29 and ID23-1.

PY - 2018/12/5

Y1 - 2018/12/5

N2 - To combat the rise of antimicrobial resistance, the discovery of new antibiotics is paramount. Albicidin and cystobactamid are related natural product antibiotics with potent activity against Gram-positive and, crucially, Gram-negative pathogens. AlbA has been reported to neutralize albicidin by binding it with nanomolar affinity. To understand this potential resistance mechanism, we determined structures of AlbA and its complex with albicidin. The structures revealed AlbA to be comprised of two domains, each unexpectedly resembling the multiantibiotic neutralizing protein TipA. Binding of the long albicidin molecule was shared pseudosymmetrically between the two domains. The structure also revealed an unexpected chemical modification of albicidin, which we demonstrate to be promoted by AlbA, and to reduce albicidin potency; we propose a mechanism for this reaction. Overall, our findings suggest that AlbA arose through internal duplication in an ancient TipA-like gene, leading to a new binding scaffold adapted to the sequestration of long-chain antibiotics.

AB - To combat the rise of antimicrobial resistance, the discovery of new antibiotics is paramount. Albicidin and cystobactamid are related natural product antibiotics with potent activity against Gram-positive and, crucially, Gram-negative pathogens. AlbA has been reported to neutralize albicidin by binding it with nanomolar affinity. To understand this potential resistance mechanism, we determined structures of AlbA and its complex with albicidin. The structures revealed AlbA to be comprised of two domains, each unexpectedly resembling the multiantibiotic neutralizing protein TipA. Binding of the long albicidin molecule was shared pseudosymmetrically between the two domains. The structure also revealed an unexpected chemical modification of albicidin, which we demonstrate to be promoted by AlbA, and to reduce albicidin potency; we propose a mechanism for this reaction. Overall, our findings suggest that AlbA arose through internal duplication in an ancient TipA-like gene, leading to a new binding scaffold adapted to the sequestration of long-chain antibiotics.

UR - http://www.scopus.com/inward/record.url?scp=85058095234&partnerID=8YFLogxK

U2 - 10.1021/jacs.8b08895

DO - 10.1021/jacs.8b08895

M3 - Article

C2 - 30422653

AN - SCOPUS:85058095234

VL - 140

SP - 16641

EP - 16649

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 48

ER -